• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺泡灌洗液中五聚素 3(PTX-3)水平作为肺癌的生物标志物。

Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker.

机构信息

Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.

Central Sterile Supply Department, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.

出版信息

Dis Markers. 2020 Jun 10;2020:4652483. doi: 10.1155/2020/4652483. eCollection 2020.

DOI:10.1155/2020/4652483
PMID:32587638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7303750/
Abstract

In this study, we investigated the utility of pentraxin 3 (PTX-3) in bronchoalveolar lavage fluid (BALF) as lung cancer (LCa) diagnostic. A total of 89 LCa patients and 84 non-LCa patients who received bronchoscopy in the First Affiliated Hospital of Xi'an Jiaotong University from December 2014 to February 2015 were enrolled. LCa was subdivided according to pathological type (scale, gland, and small cell lung cancer). BALF samples were obtained during bronchoscopy and PTX-3 levels assayed by ELISA. -tests, Mann-Whitney, and Kruskal-Wallis tests were performed for the comparison of PTX-3 levels between the different groups. Correlation analysis and receiver operating characteristic (ROC) analysis were used to analyze clinical data. The levels of PTX-3 increased in the LCa groups. PTX-3 levels were higher in the small cell lung cancer (SCLC) compared to non-small-cell lung cancer (NSCLC) groups. In LCa patients, obstructive pneumonia could upregulate the expression of PTX-3 in BALF. The area under the ROC curve of PTX-3 in BALF during LCa diagnosis, SCLC, and LCa with obstructive pneumonia was 0.949 ( ≤ 0.001), 0.672 ( < 0.05), and 0.838 ( < 0.01), respectively. In conclusion, PTX-3 in BALF has a potential value as an LCa biomarker, particularly in cases of SCLC and LCa with obstructive pneumonia.

摘要

在这项研究中,我们研究了五聚素 3(PTX-3)在支气管肺泡灌洗液(BALF)中的肺癌(LCa)诊断中的作用。2014 年 12 月至 2015 年 2 月,西安交通大学第一附属医院共纳入 89 例 LCa 患者和 84 例非 LCa 患者,接受支气管镜检查。根据病理类型(鳞癌、腺癌和小细胞肺癌)将 LCa 进一步细分。支气管镜检查时获取 BALF 样本,并通过 ELISA 测定 PTX-3 水平。采用 -检验、Mann-Whitney 和 Kruskal-Wallis 检验比较不同组之间的 PTX-3 水平。采用相关性分析和受试者工作特征(ROC)分析来分析临床数据。LCa 组的 PTX-3 水平升高。小细胞肺癌(SCLC)组的 PTX-3 水平高于非小细胞肺癌(NSCLC)组。在 LCa 患者中,阻塞性肺炎可上调 BALF 中 PTX-3 的表达。BALF 中 PTX-3 在 LCa 诊断、SCLC 和伴有阻塞性肺炎的 LCa 中的 ROC 曲线下面积分别为 0.949(≤0.001)、0.672(<0.05)和 0.838(<0.01)。总之,BALF 中的 PTX-3 作为 LCa 生物标志物具有潜在价值,特别是在 SCLC 和伴有阻塞性肺炎的 LCa 中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/3bff5a72b020/DM2020-4652483.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/b05e3605bef7/DM2020-4652483.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/6ea9ff885606/DM2020-4652483.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/0da158b308b7/DM2020-4652483.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/e0a48e5c88e7/DM2020-4652483.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/7dd8c77db485/DM2020-4652483.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/3bff5a72b020/DM2020-4652483.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/b05e3605bef7/DM2020-4652483.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/6ea9ff885606/DM2020-4652483.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/0da158b308b7/DM2020-4652483.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/e0a48e5c88e7/DM2020-4652483.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/7dd8c77db485/DM2020-4652483.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d78/7303750/3bff5a72b020/DM2020-4652483.006.jpg

相似文献

1
Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker.肺泡灌洗液中五聚素 3(PTX-3)水平作为肺癌的生物标志物。
Dis Markers. 2020 Jun 10;2020:4652483. doi: 10.1155/2020/4652483. eCollection 2020.
2
Clinical significance and prognostic value of pentraxin-3 as serologic biomarker for lung cancer.五聚体蛋白3作为肺癌血清生物标志物的临床意义及预后价值
Asian Pac J Cancer Prev. 2013;14(7):4215-21. doi: 10.7314/apjcp.2013.14.7.4215.
3
Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer.Pentraxin-3作为小细胞肺癌患者的预后标志物
Med Oncol. 2014 Oct;31(10):207. doi: 10.1007/s12032-014-0207-1. Epub 2014 Sep 2.
4
Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.使用支气管肺泡灌洗液和集成直接进样/气相色谱质谱平台对潜在肺癌生物标志物进行代谢谱分析。
J Proteomics. 2016 Aug 11;145:197-206. doi: 10.1016/j.jprot.2016.05.030. Epub 2016 May 30.
5
[Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].[非小细胞肺癌(NSCLC)患者血清和支气管肺泡灌洗液中白细胞介素-6水平的评估]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Jul;21(4):507-9.
6
Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.通过SWATH-MS数据非依赖采集和靶向数据提取发现支气管肺泡灌洗流体中肺腺癌的潜在蛋白质生物标志物
J Proteomics. 2016 Apr 14;138:106-14. doi: 10.1016/j.jprot.2016.02.010. Epub 2016 Feb 18.
7
Analyzing the percentage of different PD-1 T cell subsets in peripheral blood and bronchoalveolar lavage fluid of small cell lung cancer patients: A prospective study.分析小细胞肺癌患者外周血和支气管肺泡灌洗液中不同 PD-1 T 细胞亚群的比例:一项前瞻性研究。
Clin Exp Pharmacol Physiol. 2019 Dec;46(12):1074-1083. doi: 10.1111/1440-1681.13153. Epub 2019 Aug 30.
8
IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).IL-11 和 CCL-1:支气管肺泡灌洗液(BALF)中肺腺癌的新型蛋白诊断生物标志物。
J Thorac Oncol. 2016 Dec;11(12):2183-2192. doi: 10.1016/j.jtho.2016.07.026. Epub 2016 Aug 12.
9
Quantitative proteomic analysis of bronchoalveolar lavage fluids from patients with small cell lung cancers.小细胞肺癌患者支气管肺泡灌洗液的定量蛋白质组学分析。
Proteomics Clin Appl. 2023 Sep;17(5):e2300011. doi: 10.1002/prca.202300011. Epub 2023 Mar 1.
10
Vascular Endothelial Growth Factor-D (VEGF-D) is Elevated in Bronchoalveolar Lavage Fluid of Patients with Lung Squamous Carcinoma.血管内皮生长因子-D(VEGF-D)在肺鳞癌患者支气管肺泡灌洗液中升高。
Clin Lab. 2019 Jan 1;65(1). doi: 10.7754/Clin.Lab.2018.180712.

引用本文的文献

1
PTX3 as a diagnostic and prognostic biomarker in lung adenocarcinoma: a comprehensive analysis.PTX3作为肺腺癌诊断和预后生物标志物的综合分析
Discov Oncol. 2025 Jun 19;16(1):1158. doi: 10.1007/s12672-025-02983-5.
2
Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma.五聚体蛋白3:胶质母细胞瘤肿瘤微环境中炎症和免疫系统功能障碍的主要驱动因素
Cancers (Basel). 2024 Apr 24;16(9):1637. doi: 10.3390/cancers16091637.
3
PTX3 promotes breast cancer cell proliferation and metastasis by regulating PKCζbreast cancer, pentraxin 3, protein kinase Cζ, proliferation, metastasis.

本文引用的文献

1
Pentraxin-3 as a Biomarker for Febrile Neutropenia in Patients with Lung Cancer.血清淀粉样蛋白A3作为肺癌患者发热性中性粒细胞减少症的生物标志物
Osaka City Med J. 2015 Jun;61(1):43-52.
2
Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.肺癌患者中五聚体蛋白3局部和循环水平的预后及诊断潜力
Int J Cancer. 2016 Feb 15;138(4):983-91. doi: 10.1002/ijc.29822. Epub 2015 Sep 8.
3
Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer.Pentraxin-3作为小细胞肺癌患者的预后标志物
PTX3通过调节PKCζ促进乳腺癌细胞增殖和转移 乳腺癌、五聚体蛋白3、蛋白激酶Cζ、增殖、转移
Exp Ther Med. 2024 Feb 1;27(3):124. doi: 10.3892/etm.2024.12412. eCollection 2024 Mar.
4
Role of long pentraxin PTX3 in cancer.长 pentraxin PTX3 在癌症中的作用。
Clin Exp Med. 2023 Dec;23(8):4401-4411. doi: 10.1007/s10238-023-01137-7. Epub 2023 Jul 12.
5
Insights into the Relationship between Pentraxin-3 and Cancer.Pentraxin-3 与癌症关系的研究进展。
Int J Mol Sci. 2022 Dec 4;23(23):15302. doi: 10.3390/ijms232315302.
6
Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.核心基因参与急性肺损伤的调控及其与 COVID-19 和肿瘤进展的关系:生物信息学和实验研究。
PLoS One. 2021 Nov 22;16(11):e0260450. doi: 10.1371/journal.pone.0260450. eCollection 2021.
Med Oncol. 2014 Oct;31(10):207. doi: 10.1007/s12032-014-0207-1. Epub 2014 Sep 2.
4
Efficacy of PTX3 and posaconazole combination in a rat model of invasive pulmonary aspergillosis.PTX3与泊沙康唑联合用药在大鼠侵袭性肺曲霉病模型中的疗效
Antimicrob Agents Chemother. 2014 Oct;58(10):6284-6. doi: 10.1128/AAC.03038-14. Epub 2014 Jul 28.
5
Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.Pentraxin 3:预测前列腺炎症向前列腺癌进展的新型生物标志物。
Cancer Res. 2014 Aug 15;74(16):4230-8. doi: 10.1158/0008-5472.CAN-14-0369. Epub 2014 Jun 20.
6
Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.骨转移性乳腺癌中升高的五聚体蛋白3与溶骨功能相关。
Oncotarget. 2014 Jan 30;5(2):481-92. doi: 10.18632/oncotarget.1664.
7
Pentraxins: structure, function, and role in inflammation.五聚体蛋白:结构、功能及在炎症中的作用
ISRN Inflamm. 2013 Sep 14;2013:379040. doi: 10.1155/2013/379040.
8
Clinical significance and prognostic value of pentraxin-3 as serologic biomarker for lung cancer.五聚体蛋白3作为肺癌血清生物标志物的临床意义及预后价值
Asian Pac J Cancer Prev. 2013;14(7):4215-21. doi: 10.7314/apjcp.2013.14.7.4215.
9
Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production.ficolin-1-PTX3 复合物的形成可促进清除自身改变的细胞,并调节 IL-8 的产生。
J Immunol. 2013 Aug 1;191(3):1324-33. doi: 10.4049/jimmunol.1300382. Epub 2013 Jul 1.
10
The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas.长 pentraxin PTX3 作为胶质瘤中与癌症相关炎症和恶性程度预后的相关性标志物。
J Neuroimmunol. 2013 Jul 15;260(1-2):99-106. doi: 10.1016/j.jneuroim.2013.04.009. Epub 2013 May 9.